Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician's office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 2020–2022

September 2020 | 275 pages | ID: C142938D8004EN
Allied Market Research

Abstracts

The global covid-19 diagnostics market size is anticipated to reach $17,203.38 million till the end of 2020. Covid-19 is an infectious disease caused by a newly discovered coronavirus with a nomenclature Sars Cov 2.The virus strain shows significant similarity with an earlier detected virus, Sars Cov. The virus outbreak started from Wuhan city of China and is now spread across 210 countries and territories around the world and 2 international conveyances, as per Worldometer data.

Significant increase in the incidences of covid-19 across the globe and rise in mortality rates due to the outbreak are the major factors that drive the market growth. Moreover, technological developments and introduction of various test kits by companies worldwide propels the market growth. However, dearth of diagnosis kits in developing economies is anticipated to hamper the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a fast pace.

KEY BENEFITS FOR STAKEHOLDERS

• This report provides a detailed quantitative analysis of the current Covid-19 diagnostics market trends and forecast estimations from 2020 to 2022, which assists to identify the prevailing market opportunities.
• An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of factors that drive and restrain the covid-19 market growth is provided.
• The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2022, in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook.

KEY MARKET SEGMENTS

• By Product
• PCR Kits
• POC Kits
• Immuno Assay

By Technology

• Molecular
• Immunoassay

By End User

• Hospitals
• Physician's office and urgent care clinics
• Diagnostic Labs

By Region

• North America
• U.S.
• Canada
• Mexico
• Rest of North America
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Estonia
• Austria
• Czech Republic
• Rest of Europe
• Asia-Pacific
• China
• India
• Australia
• Japan
• South Korea
• Thailand
• Malaysia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Israel
• Rest of LAMEA

KEY MARKET PLAYERS

• F. Hoffmann-La Roche AG
• Seegene Inc.
• Cepheid
• Mylab Lifesolutions Pvt. Ltd.
• SureScreen Diagnostics Ltd
• Thermo Fisher Scientific
• Genematrix
• Robert Bosch GmbH
• Cellex

Contents

CHAPTER 1: INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
  1.3.1.Secondary research
  1.3.2.Primary research
  1.3.3.Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Market dynamics
  3.3.1.Drivers
    3.3.1.1.Significant increase in incidences of COVID-19 infection
    3.3.1.2.Unavailability of specific medicines/ vaccines
  3.3.2.Restraints
    3.3.2.1.Lack of COVID-19 diagnostic kits
  3.3.3.Opportunity
    3.3.3.1.Growth opportunities in emerging economies
3.4.Insights on antigen-based testing
3.5.Market share analysis

CHAPTER 4: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1.Overview
  4.1.1.Approved COVID-19 Diagnostic Products
  4.1.2.Market size and forecast, by technology
4.2.Molecular assay
  4.2.1.Key market trends and opportunities
  4.2.2.Market size and forecast, by region
4.3.Immunoassay/Serology
  4.3.1.Key market trends and opportunities
  4.3.2.Market size and forecast, by region

CHAPTER 5: COVID-19 DIAGNOSTICS MARKET, BY PRODUCT

5.1.Overview
  5.1.1.Market size and forecast, by product
5.2.PCR Kits
  5.2.1.Market size and forecast, by region
5.3.Immunoassay test
  5.3.1.Market size and forecast, by region
5.4.POC (Point -of-care) test
  5.4.1.Market size and forecast, by region

CHAPTER 6: COVID-19 DIAGNOSTICS MARKET, BY END USER

6.1.Overview
  6.1.1.Market size and forecast, by end user
6.2.Hospitals
  6.2.1.Market size and forecast, by region
6.3.Diagnostic laboratories
  6.3.1.Market size and forecast, by region
6.4.Physician offices & urgent care clinics
  6.4.1.Market size and forecast, by region

CHAPTER 7: COVID-19 DIAGNOSTICS MARKET, BY REGION

7.1.Overview
  7.1.1.Market size and forecast
7.2.North America
  7.2.1.Key market trends and opportunities
  7.2.2.Market size and forecast, by country
    7.2.2.1.U.S. market size and forecast, by technology
    7.2.2.2.U.S. market size and forecast, by product
    7.2.2.3.U.S. market size and forecast, by end user
    7.2.2.4.Canada market size and forecast, by technology
    7.2.2.5.Canada market size and forecast, by product
    7.2.2.6.Canada. market size and forecast, by end user
    7.2.2.7.Mexico market size and forecast, by technology
    7.2.2.8.Mexico market size and forecast, by product
    7.2.2.9.Mexico. market size and forecast, by end user
7.3.Europe
  7.3.1.Key market trends
  7.3.2.Market size and forecast, by country
    7.3.2.1.France market size and forecast, by technology
    7.3.2.2.France market size and forecast, by product
    7.3.2.3.France market size and forecast, by end user
    7.3.2.4.UK market size and forecast, by technology
    7.3.2.5.UK market size and forecast, by product
    7.3.2.6.UK. market size and forecast, by end user
    7.3.2.7.Germany market size and forecast, by technology
    7.3.2.8.Germany market size and forecast, by product
    7.3.2.9.Germany market size and forecast, by end user
    7.3.2.10.Spain market size and forecast, by technology
    7.3.2.11.Spain market size and forecast, by product
    7.3.2.12.Spain market size and forecast, by end user
    7.3.2.13.Italy market size and forecast, by technology
    7.3.2.14.Italy market size and forecast, by product
    7.3.2.15.Italy market size and forecast, by end user
    7.3.2.16.Austria market size and forecast, by technology
    7.3.2.17.Austria market size and forecast, by product
    7.3.2.18.Austria market size and forecast, by end user
    7.3.2.19.Estonia market size and forecast, by technology
    7.3.2.20.Estonia market size and forecast, by product
    7.3.2.21.Estonia market size and forecast, by end user
    7.3.2.22.Czech Republic market size and forecast, by technology
    7.3.2.23.Czech Republic market size and forecast, by product
    7.3.2.24.Czech Republic market size and forecast, by end user
    7.3.2.25.Rest of Europe market size and forecast, by technology
    7.3.2.26.Rest of Europe market size and forecast, by product
    7.3.2.27.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
  7.4.1.Key market trends and opportunities
  7.4.2.Market size and forecast, by country
    7.4.3.1.Japan market size and forecast, by technology
    7.4.3.2.Japan market size and forecast, by product
    7.4.3.3.Japan market size and forecast, by end user
    7.4.3.4.China market size and forecast, by technology
    7.4.3.5.China market size and forecast, by product
    7.4.3.6.China market size and forecast, by end user
    7.4.3.7.India market size and forecast, by technology
    7.4.3.8.India market size and forecast, by product
    7.4.3.9.India market size and forecast, by end user
    7.4.3.10.Australia market size and forecast, by technology
    7.4.3.11.Australia market size and forecast, by product
    7.4.3.12.Australia market size and forecast, by end user
    7.4.3.13.South Korea market size and forecast, by technology
    7.4.3.14.South Korea market size and forecast, by product
    7.4.3.15.South Korea market size and forecast, by end user
    7.4.3.16.Thailand market size and forecast, by technology
    7.4.3.17.Thailand market size and forecast, by product
    7.4.3.18.Thailand market size and forecast, by end user
    7.4.3.19.Malaysia market size and forecast, by technology
    7.4.3.20.Malaysia market size and forecast, by product
    7.4.3.21.Malaysia market size and forecast, by end user
    7.4.3.22.Rest of Asia-Pacific market size and forecast, by technology
    7.4.3.23.Rest of Asia-Pacific market size and forecast, by product
    7.4.3.24.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
  7.5.1.Key market trends and opportunities
  7.5.2.Market size and forecast, by country
    7.5.2.1.Brazil market size and forecast, by technology
    7.5.2.2.Brazil market size and forecast, by product
    7.5.2.3.Brazil market size and forecast, by end user
    7.5.2.4.South Africa market size and forecast, by technology
    7.5.2.5.South Africa market size and forecast, by product
    7.5.2.6.South Africa market size and forecast, by end user
    7.5.2.7.Saudi Arabia market size and forecast, by technology
    7.5.2.8.Saudi Arabia market size and forecast, by product
    7.5.2.9.Saudi Arabia market size and forecast, by end user
    7.5.2.10.Israel market size and forecast, by technology
    7.5.2.11.Israel market size and forecast, by product
    7.5.2.12.Israel market size and forecast, by end user
    7.5.2.13.Rest of LAMEA market size and forecast, by technology
    7.5.2.14.Rest of LAMEA market size and forecast, by product
    7.5.2.15.Rest of LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1.ABBOTT LABORATORIES
  8.1.1.Company overview
  8.1.2.Company snapshot
  8.1.3.Operating business segments
  8.1.4.Product portfolio
  8.1.5.Business performance
  8.1.6.Key strategic moves and developments
8.2.CELLEX INCORPORATED
  8.2.1.Company overview
  8.2.2.Company snapshot
  8.2.3.Operating business segments
  8.2.4.Product portfolio
  8.2.5.Key strategic moves and developments
8.3.CEPHEID
  8.3.1.Company overview
  8.3.2.Company snapshot
  8.3.3.Operating business segments
  8.3.4.Product portfolio
  8.3.5.Key strategic moves and developments
8.4.F. HOFFMANN-LA ROCHE LTD.
  8.4.1.Company overview
  8.4.2.Company snapshot
  8.4.3.Operating business segments
  8.4.4.Product portfolio
  8.4.5.Business performance.
  8.4.6.Key strategic moves and developments
8.5.HOLOGIC, INC.
  8.5.1.Company overview
  8.5.2.Company snapshot
  8.5.3.Operating business segments
  8.5.4.Product portfolio
  8.5.5.Business performance
  8.5.6.Key strategic moves and developments
8.6.LABORATORY CORP OF AMERICA HOLDINGS
  8.6.1.Company overview
  8.6.2.Company snapshot
  8.6.3.Operating business segments
  8.6.4.Product portfolio
  8.6.5.Business performance
  8.6.6.Key strategic moves and developments
8.7.MYLABDISCOVERY SOLUTIONS PVT. LTD.
  8.7.1.Company overview
  8.7.2.Company snapshot
  8.7.3.Operating business segments
  8.7.4.Product portfolio
  8.7.5.Key strategic moves and developments
8.8.QUEST DIAGNOSTICS INCORPORATED
  8.8.1.Company overview
  8.8.2.Company snapshot
  8.8.3.Operating business segments
  8.8.4.Product portfolio
  8.8.5.Business performance
  8.8.6.Key strategic moves and developments
8.9.SEEGENE INC.
  8.9.1.Company overview
  8.9.2.Company snapshot
  8.9.3.Operating business segments
  8.9.4.Product portfolio
  8.9.5.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
  8.10.1.Company overview
  8.10.2.Company snapshot
  8.10.3.Operating business segments
  8.10.4.Product portfolio
  8.10.5.Business performance
  8.10.6.Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 01.ANTIGEN-BASED TEST KIT AND MANUFACTURERS
TABLE 02.APPROVED COVID-19 DIAGNOSTIC PRODUCTS
TABLE 03.COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 04.COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 05.COVID-19 DIAGNOSTICS MARKET,BY TECHNOLOGY, 2022 ($MILLION)
TABLE 06.COVID-19 DIAGNOSTICS MARKET FOR MOLECULAR ASSAY, BY REGION, 2020 ($MILLION)
TABLE 07.COVID-19 DIAGNOSTICS MARKET FOR MOLECULAR ASSAY, BY REGION, 2021 ($MILLION)
TABLE 08.COVID-19 DIAGNOSTICS MARKET FOR MOLECULAR ASSAY, BY REGION, 2022 ($MILLION)
TABLE 09.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2020 ($MILLION)
TABLE 10.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2021 ($MILLION)
TABLE 11.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2022 ($MILLION)
TABLE 12.COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 13.COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 14.COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 15.COVID-19 DIAGNOSTICS MARKET, FOR PCR KITS, BY REGION, 2020 ($MILLION)
TABLE 16.COVID-19 DIAGNOSTICS MARKET, FOR PCR KITS, BY REGION, 2021 ($MILLION)
TABLE 17.COVID-19 DIAGNOSTICS MARKET, FOR PCR KITS, BY REGION, 2022 ($MILLION)
TABLE 18.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY TEST, BY REGION, 2020 ($MILLION)
TABLE 19.COVID-19 DIAGNOSTICS MARKET, FOR IMMUNOASSAY TEST, BY REGION, 2021 ($MILLION)
TABLE 20.COVID-19 DIAGNOSTICS MARKET, FOR IMMUNOASSAY TEST, BY REGION, 2022 ($MILLION)
TABLE 21.COVID-19 DIAGNOSTICS MARKET FOR POC TEST KITS, BY REGION, 2020 ($MILLION)
TABLE 22.COVID-19 DIAGNOSTICS MARKET, FOR POC TEST KITS, BY REGION, 2021 ($MILLION)
TABLE 23.COVID-19 DIAGNOSTICS MARKET, FOR POC TEST KITS, BY REGION, 2022 ($MILLION)
TABLE 24.COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 25.COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 26.COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 27.COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2020 ($MILLION)
TABLE 28.COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2021 ($MILLION)
TABLE 29.COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2022 ($MILLION)
TABLE 30.COVID-19 DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020 ($MILLION)
TABLE 31.COVID-19 DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021 ($MILLION)
TABLE 32.COVID-19 DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022 ($MILLION)
TABLE 33.COVID-19 DIAGNOSTICS MARKET, FOR PHYSICIAN OFFICES & URGENT CARE CLINICS, BY REGION, 2020 ($MILLION)
TABLE 34.COVID-19 DIAGNOSTICS MARKET, FOR PHYSICIAN OFFICES & URGENT CARE CLINICS, BY REGION, 2021 ($MILLION)
TABLE 35.COVID-19 DIAGNOSTICS MARKET, FOR PHYSICIAN OFFICES & URGENT CARE CLINICS, BY REGION, 2022 ($MILLION)
TABLE 36.COVID-19 DIAGNOSTICS MARKET, BY REGION, 2020–2022 ($MILLION)
TABLE 37.COVID-19 DIAGNOSTICS MARKET, BY REGION, 2020–2022 (NUMBER OF TESTS)
TABLE 38.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 ($MILLION)
TABLE 39.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 (NUMBER OF TESTS)
TABLE 40.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 ($MILLION)
TABLE 41.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 42.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 ($MILLION)
TABLE 43.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 (NUMBER OF TESTS)
TABLE 44.U.S. COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 45.U.S. COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 46.U.S. COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 47.U.S. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 48.U.S. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 49.U.S. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 50.U.S. COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 51.U.S. COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 52.U.S. COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 53.CANADA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 54.CANADA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 55.CANADA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 56.CANADA. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 57.CANADA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 58.CANADA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 59.CANADA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 60.CANADA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 61.CANADA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 62.MEXICO COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 63.MEXICO COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 64.MEXICO COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 65.MEXICO. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 66.MEXICO COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 67.MEXICO COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 68.MEXICO COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 69.MEXICO COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 70.MEXICO COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 71.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 ($MILLION)
TABLE 72.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 (NUMBER OF TESTS)
TABLE 73.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 ($MILLION)
TABLE 74.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 75.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 ($MILLION)
TABLE 76.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 77.FRANCE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 78.FRANCE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 79.FRANCE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 80.FRANCE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 81.FRANCE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 82.FRANCE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 83.FRANCE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 84.FRANCE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 85.FRANCE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 86.UK COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 87.UK COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 88.UK COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 89.UK COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 90.UK COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 91.UK COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 92.UK COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 93.UK COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 94.UK DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 95.GERMANY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 96.GERMANY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 97.GERMANY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 98.GERMANY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 99.GERMANY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 100.GERMANY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 101.GERMANY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 102.GERMANY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 103.GERMANY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 104.SPAIN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 105.SPAIN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 106.SPAIN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 107.SPAIN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 108.SPAIN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 109.SPAIN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 110.SPAIN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 111.SPAIN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 112.SPAIN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 113.ITALY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 114.ITALY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 115.ITALY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 116.ITALY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 117.ITALY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 118.ITALY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 119.ITALY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 120.ITALY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 121.ITALY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 122.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 123.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 124.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 125.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 126.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 127.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 128.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 129.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 130.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 131.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 132.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 133.ESTONIACOVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 134.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 135.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 136.ESTONIACOVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 137.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 138.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 139.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 140.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 141.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 142.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 143.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 144.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 145.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 146.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 147.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 148.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 149.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 150.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 151.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 152.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 153.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 154.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 155.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 156.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 157.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 158.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020($MILLION)
TABLE 159.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 (NUMBER OF TESTS)
TABLE 160.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021($MILLION)
TABLE 161.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 162.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022($MILLION)
TABLE 163.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 (NUMBER OF TESTS)
TABLE 164.JAPAN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 165.JAPAN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 166.JAPAN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 167.JAPAN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 168.JAPAN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 169.JAPAN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 170.JAPAN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 171.JAPAN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 172.JAPAN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 173.CHINA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 174.CHINA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 175.CHINA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 176.CHINA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 177.CHINA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 178.CHINA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 179.CHINA DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 180.CHINA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 181.CHINA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 182.INDIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 183.INDIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 184.INDIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 185.INDIACOVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 186.INDIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 187.INDIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 188.INDIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 189.INDIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 190.INDIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 191.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 192.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 193.AUSTRALIA MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 194.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 195.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 196.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 197.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 198.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 199.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 200.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 201.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 202.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 203.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 204.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 205.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 206.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 207.SOUTH KOREACOVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 208.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 209.THAILAND COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 210.THAILAND COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 211.THAILAND COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 212.THAILAND COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 213.THAILAND COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 214.THAILAND COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 215.THAILAND COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 216.THAILAND COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 217.THAILAND COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 218.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 219.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 220.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 221.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 222.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 223.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 224.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 225.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 226.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 227.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 228.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 229.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 230.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 231.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 232.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 233.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 234.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 235.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 236.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 ($MILLION)
TABLE 237.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020(NUMBER OF TESTS)
TABLE 238.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 ($MILLION)
TABLE 239.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021(NUMBER OF TESTS)
TABLE 240.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 ($MILLION)
TABLE 241.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022(NUMBER OF TESTS)
TABLE 242.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 243.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 244.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 245.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 246.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 247.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 248.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 249.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 250.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 251.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 252.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 253.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 254.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 255.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 256.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 257.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 258.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 259.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 260.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 261.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 262.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 263.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 264.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 265.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 266.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 267.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 268.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 269.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE